In the colon, loss of BCL-2 or BCL-XL does not impair intestinal homeostasis while recent data suggest that MCL1 deletion causes aberrant cell death, thereby prompting Wnt-dependent proliferation that eventually leads to tumor formation, indicating potential detrimental side-effects of targeting this protein [14, 17, 18]. The gene discussed is MCL1; the disease is neoplasm.